BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 10899245)

  • 1. Distinct effects of Broncho-Vaxom (OM-85 BV) on gp130 binding cytokines.
    Roth M; Block LH
    Thorax; 2000 Aug; 55(8):678-84. PubMed ID: 10899245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of interleukin 6 and interleukin 8 expression by Broncho-Vaxom (OM-85 BV) via C-Fos/serum responsive element.
    Keul R; Roth M; Papakonstantinou E; Nauck M; Perruchoud AP; Block LH
    Thorax; 1996 Feb; 51(2):150-4. PubMed ID: 8711646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative study of gp130 cytokine effects on corticotroph AtT-20 cells--redundancy or specificity of neuroimmunoendocrine modulators?
    Auernhammer CJ; Kopp FB; Vlotides G; Dorn F; Isele NB; Spöttl G; Cengic N; Weber MM; Senaldi G; Engelhardt D
    Neuroimmunomodulation; 2004; 11(4):224-32. PubMed ID: 15249728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactions between oncostatin M and the IL-6 signal transducer, gp130.
    Liu J; Modrell B; Aruffo A; Scharnowske S; Shoyab M
    Cytokine; 1994 May; 6(3):272-8. PubMed ID: 8054483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of interleukin (IL)-11 receptor by the human endometrium in vivo and effects of IL-11, IL-6 and LIF on the production of MMP and cytokines by human endometrial cells in vitro.
    Cork BA; Tuckerman EM; Li TC; Laird SM
    Mol Hum Reprod; 2002 Sep; 8(9):841-8. PubMed ID: 12200462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncostatin M binds directly to gp130 and behaves as interleukin-6 antagonist on a cell line expressing gp130 but lacking functional oncostatin M receptors.
    Sporeno E; Paonessa G; Salvati AL; Graziani R; Delmastro P; Ciliberto G; Toniatti C
    J Biol Chem; 1994 Apr; 269(15):10991-5. PubMed ID: 8157624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of receptors for interleukin-6, interleukin-11, leukemia inhibitory factor, oncostatin M, and ciliary neurotrophic factor in bone marrow stromal/osteoblastic cells.
    Bellido T; Stahl N; Farruggella TJ; Borba V; Yancopoulos GD; Manolagas SC
    J Clin Invest; 1996 Jan; 97(2):431-7. PubMed ID: 8567964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific inhibition of IL-6 signalling with monoclonal antibodies against the gp130 receptor.
    Liautard J; Sun RX; Cotte N; Gaillard JP; Mani JC; Klein B; Brochier J
    Cytokine; 1997 Apr; 9(4):233-41. PubMed ID: 9112331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-6 receptor antagonists inhibit interleukin-11 biological activity.
    Sun RX; Gennaro C; Rocco S; Gu ZJ; Klein B
    Eur Cytokine Netw; 1997 Mar; 8(1):51-6. PubMed ID: 9110148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LIF and OM directly interact with a soluble form of gp130, the IL-6 receptor signal transducing subunit.
    Modrell B; Liu J; Miller H; Shoyab M
    Growth Factors; 1994; 11(2):81-91. PubMed ID: 7857660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic effects of glycoprotein 130 binding cytokines in combination with interleukin-1 on cartilage collagen breakdown.
    Rowan AD; Koshy PJ; Shingleton WD; Degnan BA; Heath JK; Vernallis AB; Spaull JR; Life PF; Hudson K; Cawston TE
    Arthritis Rheum; 2001 Jul; 44(7):1620-32. PubMed ID: 11465713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ciliary neurotropic factor, interleukin 11, leukemia inhibitory factor, and oncostatin M are growth factors for human myeloma cell lines using the interleukin 6 signal transducer gp130.
    Zhang XG; Gu JJ; Lu ZY; Yasukawa K; Yancopoulos GD; Turner K; Shoyab M; Taga T; Kishimoto T; Bataille R
    J Exp Med; 1994 Apr; 179(4):1337-42. PubMed ID: 8145045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formation of autocrine loops in human cerebral meningioma tissue by leukemia inhibitor factor, interleukin-6, and oncostatin M: inhibition of meningioma cell growth in vitro by recombinant oncostatin M.
    Schrell UM; Koch HU; Marschalek R; Schrauzer T; Anders M; Adams E; Fahlbusch R
    J Neurosurg; 1998 Mar; 88(3):541-8. PubMed ID: 9488310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a gp130 cytokine receptor critical site involved in oncostatin M response.
    Olivier C; Auguste P; Chabbert M; Lelièvre E; Chevalier S; Gascan H
    J Biol Chem; 2000 Feb; 275(8):5648-56. PubMed ID: 10681548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-6 signal transducer gp130 mediates oncostatin M signaling.
    Liu J; Modrell B; Aruffo A; Marken JS; Taga T; Yasukawa K; Murakami M; Kishimoto T; Shoyab M
    J Biol Chem; 1992 Aug; 267(24):16763-6. PubMed ID: 1324910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AIDS-associated Kaposi's sarcoma (KS) cells express oncostatin M (OM)-specific receptor but not leukemia inhibitory factor/OM receptor or interleukin-6 receptor. Complete block of OM-induced KS cell growth and OM binding by anti-gp130 antibodies.
    Murakami-Mori K; Taga T; Kishimoto T; Nakamura S
    J Clin Invest; 1995 Sep; 96(3):1319-27. PubMed ID: 7657807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-6 signal transducer gp130 has specific binding sites for different cytokines as determined by antagonistic and agonistic anti-gp130 monoclonal antibodies.
    Wijdenes J; Heinrich PC; Müller-Newen G; Roche C; Gu ZJ; Clément C; Klein B
    Eur J Immunol; 1995 Dec; 25(12):3474-81. PubMed ID: 8566040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Definition of receptor binding sites on human interleukin-11 by molecular modeling-guided mutagenesis.
    Tacken I; Dahmen H; Boisteau O; Minvielle S; Jacques Y; Grötzinger J; Küster A; Horsten U; Blanc C; Montero-Julian FA; Heinrich PC; Müller-Newen G
    Eur J Biochem; 1999 Oct; 265(2):645-55. PubMed ID: 10504396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Six different cytokines that share GP130 as a receptor subunit, induce serum amyloid A and potentiate the induction of interleukin-6 and the activation of the hypothalamus-pituitary-adrenal axis by interleukin-1.
    Benigni F; Fantuzzi G; Sacco S; Sironi M; Pozzi P; Dinarello CA; Sipe JD; Poli V; Cappelletti M; Paonessa G; Pennica D; Panayotatos N; Ghezzi P
    Blood; 1996 Mar; 87(5):1851-4. PubMed ID: 8634432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokines that use gp130 as a signal transducer stimulate mouse placental lactogen-I (mPL-I) but inhibit mPL-II production in vitro.
    Yamaguchi M; Taga T; Kishimoto T; Miyake A
    Biol Reprod; 1995 Aug; 53(2):399-406. PubMed ID: 7492693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.